(Q30977332)

English

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population (English)

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

author name string

Yumi Asukai

1

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Amparo Valladares

2

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Eifiona Wood

4

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Kaisa Taipale

5

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Jorge Arellano

6

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Alejo Cassinello

7

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

José Antonio Sacristán

8

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Tatiana Dilla

9

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

language of work or name

0 references

publication date

29 January 2010

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

10

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

26

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-26

0 references

Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Health state utilities for non small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841662

21 June 2018

Lung cancer mortality trends in Spain between 1980 and 2005

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Second-line treatment of advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Systematic reviews and meta-analysis of febrile neutropenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Resource consumption and costs of palliative care services in Spain: a multicenter prospective study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-26

21 January 2018

[What is an efficient health technology in Spain?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20113499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Características del carcinoma broncopulmonar en una región del norte de España

1 reference

https://pubmed.ncbi.nlm.nih.gov/20113499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Epidemiology of lung cancer in Spain and forecast for the future]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20113499

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-26

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30977332&oldid=1976247116"